Go to Home

Dr. Wang Liping, Director of the Institute of Biomedical Engineering at Shenzhen Institutes of Advanced Technology (CAS), Visits Jingrui Medical to Deepen Comprehensive Strategic Cooperation

2026-03-24Press Releases
Dr. Wang Liping, Director of the Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, Visits Jingrui Medical to Deepen Comprehensive Strategic Partnership

Recently, Director Wang Liping of the Institute of Brain Cognition and Brain Diseases at Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences (CAS), along with his team, visited Jingrui Medical Technology Co., Ltd. ("Jingrui Medical"). Mr. Chen Hongchao, Chairman of Jingrui Medical, warmly welcomed Director Wang and personally hosted the visit. Both sides engaged in in-depth discussions on technological innovation, research collaboration, and industrial development in the field of brain-computer interfaces.

At the Jingrui Medical exhibition hall, Chairman Chen Hongchao provided Director Wang Liping with a detailed overview of the company's history, core technological advantages, and its "Rehabilitation Robotics" product portfolio. Director Wang highly commended Jingrui Medical's progress at the intersection of rehabilitation engineering and neuroscience. He noted that with an aging population and a rising number of patients with neurological disorders, intelligent and precise rehabilitation solutions have become a critical national priority. The Shenzhen Institutes of Advanced Technology (SIAT), Chinese Academy of Sciences, has long been dedicated to research on brain cognitive mechanisms and the development of neuro-disease intervention technologies. Given Jingrui Medical's solid foundation in commercializing rehabilitation robotics and clinical implementation, there is significant potential for collaboration between both parties.

Subsequently, both parties engaged in pragmatic discussions on multiple fronts, including brain-computer interfaces (BCI), virtual reality-based rehabilitation training systems, multi-center clinical studies, and the establishment of joint laboratories. Moving forward, the two sides will forge a comprehensive strategic partnership, leveraging their respective strengths in basic research, technology development, clinical application, and industrial commercialization. Together, they aim to drive deep integration between rehabilitation robotics and brain science, accelerate the translation of scientific achievements into real-world productivity, and support China's innovation and industrial upgrading in high-end medical equipment.

This collaboration marks a pivotal step forward for Jingrui Medical in advancing industry-academia-research innovation. Building on this momentum, the company will deepen its partnerships with leading research institutions to continuously enhance the technological sophistication and clinical value of its products. By delivering efficient, intelligent, and personalized rehabilitation services to more patients, Jingrui Medical remains committed to its mission: "Empowering Rehabilitation with Technology, Safeguarding Health with Intelligence."

Learn more

Explore more Jielitong products and solutions